Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours Β· Estimated delivery Aug 16 - Aug 21
Delays in starting treatment
GLP 3 (Reta) A synthetic triple GIP, GLP-1, and glucagon receptor agonist (39-amino-acid incretin analog), supplied as sterile lyophilized powder for in-vitro metabolic research
It needs to support the brands identity, contribute to the perceived expertise of the company, and create new opportunities for revenue growth
While injectable forms are less common for this molecule, they would bypass first-pass metabolism, likely resulting in a different pharmacokinetic profile and potentially altering the perceived half-life
US$ 25.64
US$ 21.17
US$ 24.68
